Health Condition 1: R73- Elevated blood glucose level
Conditions
Interventions
Intervention1: Individualized homeopathic medicines plus concomitant care: The intervention is planned to involve administering indicated homeopathic medicines in centesimal potencies (CH). Each dose
dosage and repetition will depend on the individuals requirements. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking, or brushing their teeth within 30 m
Sponsors
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cases with newly diagnosed prediabetes 2. FBS 100-125 mg/dl and/or PPBS 140-199 mg/dl and/or HbA1c% 5.7-6.4 (American Diabetes Association) 3. Age between 18 and 65 years 4. Participants of either sex or transgender
Exclusion criteria
Exclusion criteria: 1. Diagnosed cases of type I and type II DM. 2. Not providing written informed consent for participation. 3. Pregnant, puerperal, and lactating women. 4. Self-reported immunocompromised state, AIDS, hepatitis, etc. 5. Vulnerable population: Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill, or critically ill patients and mentally incompetent people. 6. Uncontrolled hypertension, nephritic syndrome, renal insufficiency, uncontrolled hypothyroidism, severe or active liver diseases, or any other uncontrolled systemic diseases affecting the quality of life or organ failure. 7. Females who regularly take oral contraceptive pills (OCPs) or combined oral contraceptives (COCs). 8. Patient under tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence (TAPS tool). 9. Undergoing homeopathic treatment for any chronic disease within the last 6 months. 10. Simultaneous participation in any other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glycosylated hemoglobin percentage (HbA1c%)Timepoint: At baseline, and after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| FBS and PPBS (post-2-hour, 75 g OGTT)Timepoint: At baseline, monthly, up to 3 months;Lipid profile, liver enzymes (ALT and AST)Timepoint: At baseline, and after 3 months;Measure Yourself Medical Outcome Profile version 2.0 (MYMOP-2)Timepoint: At baseline, monthly, up to 3 months;Short Form 12 (SF-12) health survey questionnaireTimepoint: At baseline, monthly, up to 3 months | — |
Countries
India
Contacts
Public ContactMohan Giri
D N De Homoeopathic Medical College and Hospital
Outcome results
None listed